Lymphoma FDG Avidity According to WHO Histopathologic Classification

References:

1 Michal Weiler-Sagie1, Olga Bushelev, Ron Epelbaum, Eldad J. Dann, Nissim Haim, Irit Avivi, Ayelet Ben-Barak, Yehudit Ben-Arie, Rachel Bar-Shalom, and Ora Israel. 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients. J Nucl Med 2010; 51:25–30.

2 Sally F. Barrington, N. George Mikhaeel, Lale Kostakoglu, Michel Meignan, Martin Hutchings, Stefan P. Mueller, Lawrence H. Schwartz, Emanuele Zucca, Richard I. Fisher, Judith Trotman, Otto S. Hoekstra, Rodney J. Hicks, Michael J. O’Doherty, Roland Hustinx, Alberto Biggi, and Bruce D. Cheson. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014; 32:3048-3058. 

          Home    Index    Clinical Applications  LYMPHOMAS